Myomo Inc (NYSE MKT:MYO) — Market Cap & Net Worth
Market Cap & Net Worth: Myomo Inc (MYO)
Myomo Inc (NYSE MKT:MYO) has a market capitalization of $32.84 Million ($32.84 Million) as of September 15, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #23542 globally and #5115 in its home market, demonstrating a 17.12% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Myomo Inc's stock price $1.04 by its total outstanding shares 38638653 (38.64 Million). Also see balance sheet size of Myomo Inc for a full breakdown of the balance sheet.
Myomo Inc Market Cap History: 2017 to 2026
Myomo Inc's market capitalization history from 2017 to 2026. Data shows change from $4.35 Billion to $40.18 Million (-45.09% CAGR). Also see MYO cash flow metrics for how efficiently the company converts equity into cash flow.
Myomo Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Myomo Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Myomo Inc share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.86x
Myomo Inc's market cap is 0.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $4.35 Billion | $1.56 Million | -$12.10 Million | 2788.47x | N/A |
| 2018 | $1.67 Billion | $2.44 Million | -$10.32 Million | 682.95x | N/A |
| 2019 | $348.68 Million | $3.84 Million | -$10.71 Million | 90.85x | N/A |
| 2020 | $260.04 Million | $7.58 Million | -$11.56 Million | 34.29x | N/A |
| 2021 | $264.48 Million | $13.86 Million | -$10.37 Million | 19.09x | N/A |
| 2022 | $19.76 Million | $15.56 Million | -$10.72 Million | 1.27x | N/A |
| 2023 | $193.58 Million | $19.24 Million | -$8.15 Million | 10.06x | N/A |
| 2024 | $248.83 Million | $32.55 Million | -$6.18 Million | 7.64x | N/A |
| 2025 | $35.16 Million | $40.93 Million | -$15.57 Million | 0.86x | N/A |
Competitor Companies of MYO by Market Capitalization
Companies near Myomo Inc in the global market cap rankings as of September 15, 2026. Review MYO intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Myomo Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $179.26 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #230 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #231 globally with a market cap of $108.12 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #242 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $179.26 Billion | $103.09 |
| #230 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.80 |
| #231 | Stryker Corporation | NYSE:SYK | $108.12 Billion | $281.87 |
| #242 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Myomo Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, Myomo Inc's market cap moved from $4.35 Billion to $ 40.18 Million, with a yearly change of -45.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $40.18 Million | +14.29% |
| 2025 | $35.16 Million | -85.87% |
| 2024 | $248.83 Million | +28.54% |
| 2023 | $193.58 Million | +879.66% |
| 2022 | $19.76 Million | -92.53% |
| 2021 | $264.48 Million | +1.71% |
| 2020 | $260.04 Million | -25.42% |
| 2019 | $348.68 Million | -79.11% |
| 2018 | $1.67 Billion | -61.60% |
| 2017 | $4.35 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 15th, 2026 the market cap of Myomo Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.84 Million USD |
| MoneyControl | $32.84 Million USD |
| MarketWatch | $32.84 Million USD |
| marketcap.company | $32.84 Million USD |
| Reuters | $32.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more